Your browser doesn't support javascript.
loading
Nature and impact of in-hospital complications associated with persistent critical illness.
Tseitkin, Boris; Mårtensson, Johan; Eastwood, Glenn M; Brown, Alastair; Ancona, Paolo; Lucchetta, Luca; Iwashyna, Theodore J; Robbins, Raymond; Bellomo, Rinaldo.
Afiliação
  • Tseitkin B; Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.
  • Mårtensson J; Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.
  • Eastwood GM; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Brown A; Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.
  • Ancona P; Australian and New Zealand Intensive Care Society Research Centre, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
  • Lucchetta L; Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.
  • Iwashyna TJ; Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.
  • Robbins R; Department of Intensive Care Medicine, Catholic University of the Sacred Heart, "A. Gemelli" University Hospital, Rome, Italy.
  • Bellomo R; Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.
Crit Care Resusc ; 22(4): 378-387, 2020 Dec.
Article em En | MEDLINE | ID: mdl-38046870
ABSTRACT

Background:

Persistent critical illness (PerCI) is defined as an intensive care unit (ICU) admission lasting ≥ 10 days. The in-hospital complications associated with its development are poorly understood.

Aims:

To test whether PerCI is associated with a greater prevalence, rate and specific types of in-hospital complications.

Methods:

Single-centre, retrospective, observational case-control study.

Results:

We studied 1200 patients admitted to a tertiary ICU from 2010 to 2015. Median ICU length of stay was 16 days (interquartile range [IQR], 12-23) for PerCI patients v 2.3 days (IQR, 1.1-3.7) for controls, and median hospital length of stay was 41 days (IQR, 22-75) v 8 days (IQR, 4-17) respectively. A greater proportion of PerCI patients received acute renal replacement therapy (37% v 6.8%) or underwent reintubation (17% v 1%) and/or tracheostomy (36% v 0.6%); P < 0.0001. Despite these complications, PerCI patients had similar hospital mortality (29% v 27%; P = 0.53). PerCI patients experienced a greater absolute number of complications (12.1 v 4.0 complications per patient; P < 0.0001) but had fewer exposure-adjusted complications (202 v 272 complications per 1000 hospital bed-days; P < 0.001) and a particularly high overall prevalence of specific complications.

Conclusions:

PerCI patients experience a higher prevalence, but not a higher rate, of exposure-adjusted complications. Some of these complications appear amenable to prevention, helping to define intervention targets in patients at risk of PerCI.

Funding:

Austin Hospital Intensive Care Trust Fund.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article